What hormone workup is recommended for a 1.5 cm left adrenal adenoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hormone Workup for a 1.5 cm Left Adrenal Adenoma

All patients with adrenal incidentalomas, regardless of size, should be screened for autonomous cortisol secretion using a 1 mg overnight dexamethasone suppression test. 1

Universal Screening Required

  • 1 mg dexamethasone suppression test (DST) is mandatory for all adrenal incidentalomas, taken at 11 PM with serum cortisol measured at 8 AM the following morning 1, 2
    • Cortisol ≤50 nmol/L excludes hypersecretion 1
    • Cortisol 51-138 nmol/L suggests possible autonomous cortisol secretion 1
    • Cortisol >138 nmol/L indicates cortisol hypersecretion 1

Conditional Screening Based on Clinical Features

Screen for Primary Aldosteronism IF:

  • Patient has hypertension and/or hypokalemia 1, 2
  • Measure aldosterone/renin ratio (ARR) in the morning after patient has been upright for 2 hours and seated for 5-15 minutes 1
  • ARR >20 ng/dL per ng/mL/hr has >90% sensitivity and specificity for hyperaldosteronism 1
  • Ensure patient is potassium-replete and substitute interfering medications when possible 1, 2

Screen for Pheochromocytoma IF:

  • Mass measures ≥10 HU on non-contrast CT OR HU value is unavailable 1, 2
  • Patient has symptoms of catecholamine excess (headaches, palpitations, sweating, anxiety attacks) 1
  • Measure plasma free metanephrines or 24-hour urinary metanephrines 1, 2
  • Values >2X upper limit of normal are significant 1

Important caveat: You can skip pheochromocytoma screening if the mass is unequivocally <10 HU on non-contrast CT AND the patient has no adrenergic symptoms 1

Screen for Androgen Excess IF:

  • Clinical signs of virilization are present (hirsutism, acne, voice deepening, clitoromegaly, menstrual irregularities) 1, 2
  • Adrenocortical carcinoma (ACC) is suspected based on imaging features (inhomogeneous, irregular margins, >4 cm) 1
  • Measure DHEA-S and testosterone as initial tests 1, 2
  • Extended panel if positive: 17β-estradiol, 17-OH progesterone, androstenedione, 17-OH pregnenolone, 11-deoxycorticosterone, progesterone, and estradiol 1

Critical Imaging Context

Before finalizing the hormone workup, confirm the mass characteristics on non-contrast CT 1, 2:

  • If <10 HU (lipid-rich adenoma), pheochromocytoma screening can be omitted unless symptoms are present 1
  • If ≥10 HU or indeterminate, proceed with full pheochromocytoma screening 1

Common Pitfalls to Avoid

  • Never skip cortisol screening even for small masses—autonomous cortisol secretion occurs in 5-30% of incidentalomas and impacts morbidity through metabolic complications 1, 2
  • Never perform adrenal biopsy before ruling out pheochromocytoma, as this can precipitate hypertensive crisis 1
  • Do not assume a small mass is non-functional—even 1.5 cm masses can be hormonally active, particularly for aldosterone-secreting adenomas 3
  • Recognize that co-secretion of multiple hormones (cortisol + androgens, cortisol + catecholamines) can occur and raises concern for ACC 4, 5, 6

Ancillary Testing if Abnormalities Found

  • If cortisol hypersecretion confirmed: measure plasma ACTH to confirm ACTH-independent secretion 1
  • If primary aldosteronism confirmed: perform adrenal vein sampling before considering surgery to lateralize the source 1
  • If pheochromocytoma suspected: consider genetic testing for hereditary syndromes (VHL, MEN2, familial paraganglioma) 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Laboratory Tests for Adrenal Incidentaloma Follow-up

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the best course of action for an asymptomatic elderly female patient with a stable 3cm (centimeter) adrenal gland lesion, likely an adrenal adenoma, that has been present for several years?
How to manage a patient with primary macronodular adrenal hyperplasia, presenting with hypertension and hypokalemia, and abnormal activated renin concentration and plasma renin activity (PRA) levels?
What is the initial management for a patient with an adrenal adenoma and primary aldosteronism (Hyperaldosteronism) indicated by a significantly elevated Aldosterone (Aldo) to Renin (Renin) ratio?
What is the recommended workup for a 16 mm adrenal adenoma?
What is the best course of action for a 37-year-old woman with persistent anxiety, significant unintentional weight loss, paresthesias, and cognitive impairment, who has undergone extensive negative workup, including normal thyroid studies, vitamin B12 (385 pg/mL), pheochromocytoma and celiac screens, complete blood count (CBC), metabolic panel, antinuclear antibody (ANA) test, and computed tomography (CT) of the abdomen and pelvis, with mild inflammatory markers, elevated morning cortisol (29 mcg/dL) and normal adrenocorticotropic hormone (ACTH) levels, and a history of treatment with fluoxetine (Prozac), escitalopram (Lexapro), divalproex (Depakote), buspirone (Buspar), and dextroamphetamine-amphetamine (Adderall), and recently lybalvi?
How should a patient with pyelonephritis and a normal C-Reactive Protein (CRP) level be treated?
Would a computed tomography (CT) scan of the pelvis be sufficient to evaluate a groin nodule or adenopathy?
What was the number of opioid-related deaths in the United States in 2017?
What is the preferred choice between co-amoxiclav (amoxicillin/clavulanate) and clindamycin for a patient with a suspected bacterial infection?
What is the recommended Guideline-Directed Medical Therapy (GDMT) for a patient with heart failure with reduced ejection fraction (HFrEF)?
What are the initial tests to diagnose hypothyroidism in an adult patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.